Mitochondrial beta-oxidation enzyme

Mitochondrial beta-oxidation enzymes are a set of chain-length specific enzymes within the mitochondria that catalyze the repetitive process of beta-oxidation, which cleaves two carbons off fatty acyl-CoAs to yield acetyl-CoA, NADH, and FADH₂[2][3][1]. The major classes in the pathway include acyl-CoA dehydrogenases (with isoforms for short, medium, long, and very-long chains), enoyl-CoA hydratases, 3-hydroxyacyl-CoA dehydrogenases, and 3-ketoacyl-CoA thiolases[2][4]. There is also a mitochondrial trifunctional protein complex responsible for catalyzing multiple steps, particularly for long-chain fatty acids[3][5]. Deficiencies in individual enzymes result in characteristic metabolic diseases, detectable by specific acylcarnitine biomarkers[4]. These enzymes are not a single molecular target but rather a group, so the entry as provided is overly broad and non-canonical; naming individual enzymes (e.g., "Very long-chain acyl-CoA dehydrogenase") is preferred for drug discovery or diagnostic targeting[4]. The query refers to a process involving multiple enzymes, not a specific unique molecule or canonical drug target[2][3][4]. Each enzyme (e.g., VLCAD, MCAD, SCAD, LCHAD, SCHAD, CPT1, CPT2, CACT) can itself be regarded as a canonical target. This entry is flagged as "is_incorrect: true" for being overly broad/non-canonical. No specific drugs directly target "mitochondrial beta-oxidation enzymes" as a group, but enzyme defects are treated by dietary management or, in some cases, cofactors or gene therapy approaches. Individual enzyme deficiencies (e.g., MCAD deficiency) have specific clinical management[4][1].

Other names

Mitochondrial fatty acid beta-oxidation enzymeBeta-oxidation enzymeFatty acid beta-oxidation enzymeFatty acid oxidation enzyme

Enzymatic oxidation of fatty acids to generate acetyl-CoA, FADH₂, and NADH for the tricarboxylic acid (TCA) cycle and respiratory chain